Article
Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis.
Lung cancer (Amsterdam, Netherlands) - 1 Jun 2015
Wu Ying, Liu Hongbing, Shi Xuefei, Song Yong
Abstract excerpt
BACKGROUND: The detection of epidermal growth factor receptor (EGFR) mutations in plasma or serum has previously been reported to be feasible for non-small-cell lung cancer (NSCLC). However, not all results indicate a consistency between EGFR mutation status in the plasma or serum and that in tissues. METHODS: A meta-analysis was performed to evaluate the overall accuracy of EGFR mutation detection in plasma or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.